These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5312971)

  • 1. Effect of temperature on hemostasis: a cold-tolerance test.
    Sutor AH; Bowie EJ; Owen CA
    Blut; 1971 Jan; 22(1):27-34. PubMed ID: 5312971
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleeding from standardized skin punctures: automated technic for recording time, intensity, and pattern of bleeding.
    Sutor AH; Bowie EJ; Thompson JH; Didisheim P; Mertens BF; Owen CA
    Am J Clin Pathol; 1971 May; 55(5):541-50. PubMed ID: 5314544
    [No Abstract]   [Full Text] [Related]  

  • 3. ARFI ultrasound monitoring of hemorrhage and hemostasis in vivo in canine von Willebrand disease and hemophilia.
    Scola MR; Nichols TC; Zhu H; Caughey MC; Merricks EP; Raymer RA; Margaritis P; High KA; Gallippi CM
    Ultrasound Med Biol; 2011 Dec; 37(12):2126-32. PubMed ID: 22033127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of von Willebrand's Disease.
    Mannucci PM
    N Engl J Med; 2004 Aug; 351(7):683-94. PubMed ID: 15306670
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on structure-function relationships of human antihemophilic/von Willebrand factor protein.
    McKee PA
    Ann N Y Acad Sci; 1981; 370():210-26. PubMed ID: 6791544
    [No Abstract]   [Full Text] [Related]  

  • 6. [The factor VIII complex: hemophilia A and von Willebrand disease].
    Tobelem G; Rothschild C
    Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased capillary permeability in haemophilia and afibrinogenaemia.
    Neri Serneri GG; Gensini GF; Gensini RA
    Acta Haematol; 1974; 52(6):336-44. PubMed ID: 4218695
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structure and function of clotting factor VIII: the results of fundamental research].
    Beck EA; Furlan M
    Ther Umsch; 1979 Apr; 36(4):294-300. PubMed ID: 377554
    [No Abstract]   [Full Text] [Related]  

  • 10. Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond.
    Kumar R; Carcao M
    Pediatr Clin North Am; 2013 Dec; 60(6):1419-41. PubMed ID: 24237980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of inhibitors to factor VIII.
    Kasper CK
    Prog Hematol; 1981; 12():143-63. PubMed ID: 6803298
    [No Abstract]   [Full Text] [Related]  

  • 12. DDAVP factor VIII concentrate and its properties in vivo and in vitro.
    Nilsson IM; Mikaelsson M; Vilhardt H; Walter H
    Thromb Res; 1979; 15(1-2):263-71. PubMed ID: 314686
    [No Abstract]   [Full Text] [Related]  

  • 13. Dominant inherited familial factor VIII deficiency (Von Willebrand disease) associated with thrombocytopathic thrombocytopaenia. (Biologic and genetic implications).
    Sultan Y; Bernal-Hoyos EJ; Levy-Toledano S; Jeanneau C; Caen JP
    Pathol Biol (Paris); 1974 Nov; 22 suppl():27-36. PubMed ID: 4620093
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy of hereditary disorders of blood coagulation.
    Breckenridge RT; Ratnoff OD
    Mod Treat; 1968 Jan; 5(1):39-60. PubMed ID: 4870179
    [No Abstract]   [Full Text] [Related]  

  • 15. The physiologic basis for therapy of classic hemophilia (factor 8 deficiency) and related disorders. Combined clinical staff conference at the National Institutes of Health.
    Ann Intern Med; 1967 Oct; 67(4):856-82. PubMed ID: 5299081
    [No Abstract]   [Full Text] [Related]  

  • 16. Thermal injury in von willebrand disease. Management of burn wound bleeding.
    Andes WA; Baron JP; Bowman RP; Rickles FR
    Arch Surg; 1976 Mar; 111(3):280-3. PubMed ID: 1083224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-inactivated factor VIII concentrate prevents postoperative bleeding in a patient with von Willebrand's disease.
    Furlan M; Lämmle B; Aeberhard A; Kirste E; Sulzer I
    Transfusion; 1988; 28(5):489-92. PubMed ID: 3138794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease.
    Turecek PL; Gritsch H; Richter G; Auer W; Pichler L; Schwarz HP
    Thromb Haemost; 1997 Mar; 77(3):591-9. PubMed ID: 9066015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
    Warrier AI; Lusher JM
    J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylsalicylic acid as a diagnostic aid in hemostasis.
    Quick AJ
    Am J Med Sci; 1967 Oct; 254(4):392-7. PubMed ID: 5299080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.